Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Identify and Evaluate Potential Risk Factors for…

U.S. Centers for Disease Control and Prevention - ERA·United States of America

Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)

Closes 11/30/2026$500kGrants Notice
Get bids like this by emailBid source

Description

The Centers for Disease Control and Prevention - ERA is inviting research proposals to study risk factors for Amyotrophic Lateral Sclerosis (ALS). The proposals should focus on military service, contact sports, traumatic brain injury, neuroinflammation, and infections agents and exposures. The funding will be for four funding options: Option A - Support research with strong existing evidence, Option B - Support new and exploratory research on ALS risk factors, Option C - Understand ALS risk in affected populations, and Option D - Analyze biological samples from the Guamanian ALS cluster. The key aspects of this opportunity include: • Studies on military service, contact sports, traumatic brain injury, neuroinflammation, and infections agents and exposures are encouraged. • Funding will be for four funding options. • The estimated funding for this opportunity is $4,500,000. • The award ceiling is $500,000. • The opportunity is open to various types of entities, including nonprofits, state governments, and private institutions of higher education.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Dr. Candis Hunter

ncipc_erpo@cdc.gov

(770) 488-1347

Key dates

Opened
7/8/2026
Closes
11/30/2026
Projected award
8/29/2027

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
RFA-TS-27-018

Budget estimate

$0 – $500,000

The estimated funding for this opportunity is $4,500,000, with an award ceiling of $500,000. This suggests that the budget for the selected proposals will be in the range of $0 to $500,000. The actual budget will depend on the number of awards and the funding options chosen. The factors that may influence the likely payment range include the number of proposals received, the quality of the proposals, and the availability of funds.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Food and Drug Administration·United States of America

Top match · 86%

Studies Addressing Rare Neurodegenerative Diseases including ALS

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

84% match

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Closes 5/24/2027Opened 9/23/2026

U.S. National Institutes of Health·United States of America

83% match

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Closes 11/10/2026Opened 8/28/2025

U.S. National Institutes of Health·United States of America

77% match

Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed)

Closes 7/5/2029Opened 7/29/2025

University of South Carolina·South Carolina

77% match

Notice Of Intent To Sole Source – University of South Carolina Collaborative ALS Research Services

Rolling / TBD closeOpened 10/5/2026

U.S. National Institutes of Health·United States of America

76% match

Global Brain and Nervous System Disorders Research Across the Lifespan - Exploratory Grants

Closes 11/14/2026Opened 9/26/2025

U.S. National Institutes of Health·United States of America

76% match

Learning Disabilities Research Centers

Closes 9/30/2027Opened 10/20/2026

U.S. National Institutes of Health·United States of America

76% match

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Closes 5/7/2028Opened 12/30/2024

U.S. National Institutes of Health·United States of America

76% match

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System

Closes 1/27/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

76% match

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

Closes 1/7/2028Opened 10/28/2024

U.S. Administration for Community Living·United States of America

76% match

Traumatic Brain Injury Model Systems Centers

Closes 9/29/2027Opened 9/25/2026

U.S. Food and Drug Administration·United States of America

76% match

Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required

Rolling / TBD closeOpened 8/14/2024

U.S. Centers for Disease Control and Prevention - ERA·United States of America

75% match

RFA-PS-18-000

Closes 9/30/2030Opened 10/20/2023

U.S. National Institutes of Health·United States of America

75% match

BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2029Opened 8/28/2025

U.S. Department Of Defense·Maryland

75% match

RFI Alzheimer’s Research Program (AZRP) Public

Closes 12/4/2026Opened 10/27/2026

U.S. National Institutes of Health·United States of America

75% match

Limited Competition: BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships

Closes 6/16/2027Opened 9/10/2026

U.S. Centers for Disease Control and Prevention - ERA·United States of America

75% match

RFA-DD-18-000

Closes 9/30/2030Opened 10/13/2023

U.S. National Institutes of Health·United States of America

75% match

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

Closes 11/2/2026Opened 11/6/2023

U.S. Centers for Disease Control and Prevention - ERA·United States of America

75% match

RFA-EH-18-000

Closes 9/30/2030Opened 10/20/2023

U.S. National Institutes of Health·United States of America

75% match

NIDA Avenir Program: Fundamental Mechanistic Research in Addiction Science

Closes 5/25/2027Opened 9/10/2026

U.S. Centers for Disease Control and Prevention - ERA·United States of America

75% match

RFA-DP-18-000

Closes 9/30/2030Opened 10/20/2023

U.S. Centers for Disease Control and Prevention - ERA·United States of America

75% match

RFA-CD-18-000

Closes 9/30/2030Opened 10/20/2023

U.S. National Institutes of Health·United States of America

74% match

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Closes 10/20/2027Opened 10/22/2024

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

74% match

DoW Toxic Exposures Translational Research Award

Closes 11/19/2026Opened 5/7/2026

U.S. Centers for Disease Control and Prevention - ERA·United States of America

74% match

RFA-TS-18-000

Closes 9/30/2030Opened 10/19/2023